Sandoz appeals loss in 15-year battle over Lexapro patent

Intellectual Property 2019-01-10 11:26 am By Christine Caulfield | Melbourne

Please login to bookmark

Generic drug maker Sandoz is challenging a ruling that it infringed a patent behind Lundbeck’s blockbuster antidepressant Lexapro, reviving a 15-year fight over the lucrative intellectual property.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au